Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines

PURPOSE: Myocardial late gadolinium enhancement was originally validated using higher than label-recommended doses of gadolinium chelate. The objective of this study was to evaluate available evidence for various gadolinium dosing regimens used for CMR. The relationship of gadolinium dose warnings (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nacif, Marcelo S, Arai, Andrew E, Lima, Joao AC, Bluemke, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305456/
https://www.ncbi.nlm.nih.gov/pubmed/22376193
http://dx.doi.org/10.1186/1532-429X-14-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305456/
https://www.ncbi.nlm.nih.gov/pubmed/22376193
http://dx.doi.org/10.1186/1532-429X-14-18

Ejemplares similares